BDNF and Alzheimer disease: Intraperitoneal PA injection significantly enhanced cognitive function in AD mice (Figure 5B,C and Figure S7C), substantially reduced Aβ aggregation, promoted the recruitment of microglia to plaques, and increased BDNF intensity (Figure 5D–F and Figure S7E–I).